Newer patents in antimycotic therapy (Q38743672)

6 September 2017

title

Newer patents in antimycotic therapy (English)

1 reference

6 September 2017

0 references

Sukhbir K Shahid

1

1 reference

6 September 2017

publication date

22 February 2016

1 reference

Pharmaceutical patent analyst

6 September 2017

published in

1 reference

6 September 2017

volume

5

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

115-134

1 reference

Interplay between Candida albicans and the mammalian innate host defense.

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Regulatory circuitry governing fungal development, drug resistance, and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Passive surveillance for azole-resistant Aspergillus fumigatus, United States, 2011-2013

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Epidemiology of echinocandin resistance in

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Antifungal resistance and new strategies to control fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Engineering of Glarea lozoyensis for exclusive production of the pneumocandin B0 precursor of the antifungal drug caspofungin acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Discovery of a novel broad-spectrum antifungal agent derived from albaconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

In vitro profiling of pramiconazole and in vivo evaluation in Microsporum canis dermatitis and Candida albicans vaginitis laboratory models

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Novel antifungal agents: a patent review (2011 - present).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Genetic Manipulation of the Pneumocandin Biosynthetic Pathway for Generation of Analogues and Evaluation of Their Antifungal Activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

New β-glucan inhibitors as antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

21 January 2018

Newer antifungal agents

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Heat shock protein inhibitors for the treatment of fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Recent progress regarding the bioactivities, biosynthesis and synthesis of naturally occurring resorcinolic macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Structural basis of the radicicol resistance displayed by a fungal hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Highly potential antifungal activity of quantum-sized silver nanoparticles against Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Potential role of probiotic bacteria in the treatment and prevention of localised candidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

In vitro analysis of finasteride activity against Candida albicans urinary biofilm formation and filamentation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Milbemycins: more than efflux inhibitors for fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

An insight into the antifungal pipeline: selected new molecules and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Identification of yeast genes that confer resistance to chitosan oligosaccharide (COS) using chemogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Bioactive natural products from Lysobacter.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Crambescidin-816 acts as a fungicidal with more potency than crambescidin-800 and -830, inducing cell cycle arrest, increased cell size and apoptosis in Saccharomyces cerevisiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Discovery and characterization of ß-1,6-glucan inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

1,3-Benzoxazole-4-carbonitrile as a novel antifungal scaffold of β-1,6-glucan synthesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Antifungal drug development: challenges, unmet clinical needs, and new approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Dissecting the role of dolichol in cell wall assembly in the yeast mutants impaired in early glycosylation reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Bugs, drugs and chemical genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Fungal cell wall vaccines: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Vaccines for invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

An oral vaccine against candidiasis generated by a yeast molecular display system.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Immunization with apoptotic phagocytes containing Histoplasma capsulatum activates functional CD8(+) T cells to protect against histoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Active immunization against Pneumocystis carinii with p55-v3 DNA vaccine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

The combined use of Paracoccidioides brasiliensis Pb40 and Pb27 recombinant proteins enhances chemotherapy effects in experimental paracoccidioidomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Effect of traditional Chinese medicinal herbs on Candida spp. from patients with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Mechanism of Antifungal Activity of Terpenoid Phenols Resembles Calcium Stress and Inhibition of the TOR Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Anticandidal activity of the essential oils of Thymus maroccanus and Thymus broussonetii and their synergism with amphotericin B and fluconazol

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Inhibition of hyphae formation and SIR2 expression in Candida albicans treated with fresh Allium sativum (garlic) extract

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Comparison between allicin and fluconazole in Candida albicans biofilm inhibition and in suppression of HWP1 gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Potential of Cameroonian plants and derived products against microbial infections: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Synthesis and antifungal activity of a novel series of 13-(4-isopropylbenzyl)berberine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

Onychomycosis: Diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FPPA-2015-0001

21 January 2018

Identifiers

DOI

10.4155/PPA-2015-0001

1 reference

6 September 2017

1 reference